infection
Researchers in Kilifi, Kenya, are conducting human infection studies to accelerate the development of a Shigella vaccine. The studies involve deliberately infecting healthy volunteers with the bacterium under strict medical supervision. The process aims to evaluate vaccine candidates and understand immune responses to the disease, which remains a significant public health concern, particularly in sub-Saharan […]
-
Pages